51
|
Mac-Way F, Azzouz L, Noel C, Lafage-Proust MH. Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction. J Bone Miner Metab 2014; 32:215-9. [PMID: 23794122 DOI: 10.1007/s00774-013-0480-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2012] [Accepted: 05/03/2013] [Indexed: 12/15/2022]
Abstract
Vitamin D deficiency/insufficiency is significantly prevalent in chronic kidney disease. Data in the literature are however scarce about the effects of this deficiency on bone metabolism in hemodialysis (HD) patients. Moreover, it is still debated whether low vitamin D levels should be normalized in HD patients. In this paper, we report two cases showing the deleterious consequences of vitamin D deficiency in HD patients which is characterised by hypophosphatemia, hypocalcemia and osteomalacia (OM) leading to bone fractures. As vitamin D repletion is an easy way to treat OM, this report underlines the importance of monitoring and correction of vitamin D deficiency in this population.
Collapse
|
52
|
Vantyghem MC, Defrance F, Quintin D, Leroy C, Raverdi V, Prévost G, Caiazzo R, Kerr-Conte J, Glowacki F, Hazzan M, Noel C, Pattou F, Diamenord ASB, Bresson R, Bourdelle-Hego MF, Cazaubiel M, Cordonnier M, Delefosse D, Dorey F, Fayard A, Fermon C, Fontaine P, Gillot C, Haye S, Le Guillou AC, Karrouz W, Lemaire C, Lepeut M, Leroy R, Mycinski B, Parent E, Siame C, Sterkers A, Torres F, Verier-Mine O, Verlet E, Desailloud R, Dürrbach A, Godin M, Lalau JD, Lukas-Croisier C, Thervet E, Toupance O, Reznik Y, Westeel PF. Treating diabetes with islet transplantation: lessons from the past decade in Lille. DIABETES & METABOLISM 2014; 40:108-19. [PMID: 24507950 DOI: 10.1016/j.diabet.2013.10.003] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2013] [Revised: 09/29/2013] [Accepted: 10/07/2013] [Indexed: 01/10/2023]
Abstract
Type 1 diabetes (T1D) is due to the loss of both beta-cell insulin secretion and glucose sensing, leading to glucose variability and a lack of predictability, a daily issue for patients. Guidelines for the treatment of T1D have become stricter as results from the Diabetes Control and Complications Trial (DCCT) demonstrated the close relationship between microangiopathy and HbA1c levels. In this regard, glucometers, ambulatory continuous glucose monitoring, and subcutaneous and intraperitoneal pumps have been major developments in the management of glucose imbalance. Besides this technological approach, islet transplantation (IT) has emerged as an acceptable safe procedure with results that continue to improve. Research in the last decade of the 20th century focused on the feasibility of islet isolation and transplantation and, since 2000, the success and reproducibility of the Edmonton protocol have been proven, and the mid-term (5-year) benefit-risk ratio evaluated. Currently, a 5-year 50% rate of insulin independence can be expected, with stabilization of microangiopathy and macroangiopathy, but the possible side-effects of immunosuppressants, limited availability of islets and still limited duration of insulin independence restrict the procedure to cases of brittle diabetes in patients who are not overweight or have no associated insulin resistance. However, various prognostic factors have been identified that may extend islet graft survival and reduce the number of islet injections required; these include graft quality, autoimmunity, immunosuppressant regimen and non-specific inflammatory reactions. Finally, alternative injection sites and unlimited sources of islets are likely to make IT a routine procedure in the future.
Collapse
|
53
|
Haeck M, Top I, Elsermans V, Lionet A, Provot F, Dufosse F, Hazzan M, Noel C. Protocole de désimmunisation : attention au cross match B positif sans anticorps anti HLA de classe 2. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
54
|
Bloch J, Lionet A, Hennart B, Guyon-Roger T, Garstka A, Lessoré de Ste Foy C, Allorge D, Frimat M, Noel C. Insuffisance rénale terminale secondaire à une intoxication cannabique. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
55
|
Hamdan A, Noel C, Kosior F, Henrion G, Belmonte T. Dynamics of bubbles created by plasma in heptane for micro-gap conditions. THE JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA 2013; 134:991-1000. [PMID: 23927098 DOI: 10.1121/1.4812255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The determination of the initial pressure at the bubble wall created by a discharge in heptane for micro-gap conditions cannot be determined straightforwardly by modeling the time-oscillations of the bubble. The resolution of the Gilmore equation gives the same solutions beyond 1 μs typically for various sets of initial parameters, making impossible the determination of the initial pressure at the bubble wall. Furthermore, the very first instant of the bubble formation is not easily accessible at very short time scales because of the plasma emission. Since the pressure waves propagate in the liquid, it is much easier to gain information on the first instants of the bubble formation by studying the pressure field far from the emission source. Then, it is possible to deduce by modeling what happened at the beginning of the emission of the pressure waves. The proposed solution consists in looking at the oscillations affecting another bubble located at least twice farther from the interelectrode gap than the maximum radius reached by the discharge bubble. The initial plasma pressure can be determined by this method.
Collapse
|
56
|
Ennezat PV, Noel C, Tillie-Leblond I, Le Jemtel TH, Vincentelli A. Crohn's disease and nontropical endomyocardial fibrosis. Cardiology 2013; 125:258-60. [PMID: 23839293 DOI: 10.1159/000351085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2013] [Accepted: 03/28/2013] [Indexed: 11/19/2022]
Abstract
The pathogenesis of endomyocardial fibrosis (EMF) is poorly understood. EMF may result from autoimmune scarring of the endocardium. Clinically, EMF presents as a restrictive cardiomyopathy. EMF is commonly reported in tropical countries. In Western countries, EMF is associated with hypereosinophilia and reported as Loeffler endocarditis. We report a Caucasian patient with Crohn's disease and EMF, and discuss a possible linkage between the two conditions.
Collapse
|
57
|
Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vezinet F, Masquelier B, Costagliola D, Lagier E, Roussel C, Le Guillou-Guillemette H, Alloui C, Bettinger D, Anies G, Reigadas S, Bellecave P, Pinson-Recordon P, Fleury H, Masquelier B, Vallet S, Leroux M, Dina J, Vabret A, Poveda JD, Mirand A, Henquell C, Bouvier-Alias M, Noel C, De Rougemont A, Dos Santos G, Yerly S, Gaille C, Caveng W, Chapalay S, Calmy A, Signori-Schmuck A, Morand P, Pallier C, Bocket L, Mouna L, Ranger-Rogez S, Andre P, Tardy JC, Trabaud MA, Tamalet C, Delamare C, Montes B, Schvoerer E, Andre-Garnier E, Ferre V, Cottalorda J, Guigon A, Guinard J, Descamps D, Charpentier C, Peytavin G, Brun-Vezinet F, Haim-Boukobza S, Roques AM, Soulie C, Lambert-Niclot S, Malet I, Wirden M, Fourati S, Marcelin AG, Calvez V, Flandre P, Assoumou L, Costagliola D, Morand-Joubert L, Delaugerre C, Schneider V, Amiel C, Giraudeau G, Maillard A, Plantier JC, Fafi-Kremer S, Schmitt MP, Raymond S, Izopet J, Chaillon A, Barin F, Marque Juillet S. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. J Antimicrob Chemother 2013; 68:2626-31. [DOI: 10.1093/jac/dkt238] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
58
|
Gutti V, Noel C, Yang D, Bosch W, Mutic S, Ford E, Terezakis S, Santanam L. SU-E-T-372: Quality Assurance Plan Veto (QAPV): Reincarnation of Record and Verify System and Its Potential Value. Med Phys 2013. [DOI: 10.1118/1.4814806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
59
|
Hruba P, Brabcova I, Krejcik Z, Stranecky V, Honsova E, Viklicky O, Rocchetti MT, Pontrelli P, Rascio F, Fiorentino M, Stallone G, Gesualdo L, Grandaliano G, Lemy A, Lionet A, Noel C, Couzi L, Taupin JL, Merville P, Hiesse C, Suberbielle-Boissel C, De Meyer M, Latinne D, Racape J, Wissing KM, Claas FHJ, Toungouz M, Abramowicz D, Caballero A, Ruiz-Esteban P, Leon M, Palma-Merida E, Burgos D, Cabello M, Gonzalez-Molina M, Torres A, Hernandez D, Janssen EHCC, Ledeganck KJ, Hoenderop JGJ, Verpooten GAL, De Winter BY. Transplantation - basic. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
60
|
Mottet B, Chiquet C, Aptel F, Noel C, Gronfier C, Buguet A, Romanet JP. 24-Hour Intraocular Pressure of Young Healthy Humans in Supine Position: Rhythm and Reproducibility. ACTA ACUST UNITED AC 2012; 53:8186-91. [DOI: 10.1167/iovs.12-10877] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
61
|
Green O, Hu Y, Noel C, Olsen J, Mutic S. Observation of Radiation-induced Tissue Signal Intensity Changes With the First Commercial MRI-guided IMRT System. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.2029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
62
|
Santanam L, Brame S, Wooten O, Green O, Noel C, Mutic S. Risk Analysis of Real-time Adaptive Planning Using MRI Guided Radiation Therapy (MRGRT). Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.2301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
63
|
Noel C, Santanam L, Parikh P, Mutic S. Risk Analysis for Clinical Implementation of Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
64
|
Goubet M, Jomaa Z, Lionet A, Garstka A, Frimat M, Lessoré C, Provot F, Azar R, Hazzan M, Noel C. Arrêt précoce de l’éculizumab dans le traitement d’un syndrome hémolytique et urémique atypique de l’adulte. Nephrol Ther 2012. [DOI: 10.1016/j.nephro.2012.07.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
65
|
Decambron M, Lebas C, Ducloy AS, Jourdain M, Lionet A, Lessore C, Glowacki F, Hazzan M, Noel C, Provot F. Acide tranexamique et pré-éclampsie : une liaison dangereuse ? Nephrol Ther 2012. [DOI: 10.1016/j.nephro.2012.07.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
66
|
Noel C, Olsen J, Green OP, Hu Y, Parikh P. TU-G-217A-09: Feasibility of Bowel Tracking Using Onboard Cine MRI for Gated Radiotherapy. Med Phys 2012. [DOI: 10.1118/1.4736032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
67
|
Li H, Noel C, Thorstad W, Li H, Yu L, Low D, Moore K, Mutic S. SU-E-J-176: Clinical Evaluations of a Novel Metal Artifact Reduction Technique for Treatment Planning in Radiation Therapy. Med Phys 2012; 39:3693. [DOI: 10.1118/1.4735015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
68
|
Cantaluppi V, De Lena M, Figliolini F, Beltramo S, Medica D, Tognarelli G, Biancone L, Tetta C, Segoloni GP, Camussi G, Pontrelli P, Cariello M, Verrienti R, Tataranni T, Gigante M, Loverre A, Stallone G, Schena FP, Ranieri E, Gesualdo L, Grandaliano G, Coupel S, Charreau B, Canet E, Gerard N, Charreau B, Segalen I, Alexandre N, Grall A, Jacques-Olivier P, Hillion S, Le Meur Y, Alexandre H, Dany A, Michel D, Denis G, Christophe L, Nacera O, Isabelle B, Eric R, Yi Chun DX, Buob D, Grimbert P, Glowacki F, Labalette M, Dufosse F, Nochy D, Copin MC, Boleslawski E, Noel C, Hazzan M. Transplantation basic. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
69
|
Poitou C, Francois H, Bellanne-Chantelot C, Noel C, Jacquet A, Clauin S, Beaudreuil S, Damieri H, Hebibi H, Hammoudi Y, Benoit G, Charpentier B, Durrbach A. Maturity onset diabetes of the young: clinical characteristics and outcome after kidney and pancreas transplantation in MODY3 and RCAD patients: a single center experience. Transpl Int 2012; 25:564-72. [DOI: 10.1111/j.1432-2277.2012.01458.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
70
|
Bathaei S, Vitry J, Noel C, Vambergue A, Lemaire C, Romon M. P44 Évaluation des connaissances des médecins généralistes (MG) sur la microalbuminurie (MA). DIABETES & METABOLISM 2012. [DOI: 10.1016/s1262-3636(12)71146-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
71
|
Bloch J, Provôt F, Noel LH, Glowacki F, Lionet A, Hazzan M, Noel C. Syndrome d’Alport et anévrismes artériels. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
72
|
Botte A, Glowacki F, Homs S, Lionet A, Lessore C, Provot F, Hazzan M, Lions C, Bérégi JP, Noel C. Intérêt de l’IRM cardiaque de stress dans le dépistage de la maladie coronarienne lors du bilan pré-transplantation rénale. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
73
|
Lemy A, Lionet A, Labalette M, Noel C, Hiesse C, Delahousse M, Suberbielle C, de Meyer M, Latinne D, Mourad M, Toungouz M, Abramowicz D. Impact des anticorps anti-MICA détectés en post-transplantation sur le devenir de greffe à long terme : étude multicentrique chez 779 transplantés rénaux. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
74
|
Hertig A, Buob D, Noel C, Marie-Christine C, Xu-Dubois YC, Rondeau E, Hazzan M. Impact du sevrage à trois mois en anti-calcineurines sur la fibrose interstitielle du greffon. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
75
|
Deltenre P, Moreno C, Tran A, Ollivier I, Provôt F, Stanke F, Lazrek M, Castel H, Canva V, Louvet A, Colin M, Glowacki F, Dharancy S, Henrion J, Hazzan M, Noel C, Mathurin P. Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. Aliment Pharmacol Ther 2011; 34:454-61. [PMID: 21682756 DOI: 10.1111/j.1365-2036.2011.04741.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND In end-stage renal disease (ESRD) patients, hepatitis C virus (HCV) eradication improves patient and graft survival. AIM To determine optimal use of erythropoietin (EPO) and ribavirin, to compare ribavirin concentrations with those of HCV patients having normal renal function and to evaluate sustained virological response (SVR) in a prospective observatory of ESRD candidates for renal transplantation. METHODS Thirty-two naïve patients were treated with Peg-IFN-α2a and ribavirin. Two different schedules of ribavirin and EPO administration were used: starting ribavirin at 600mg per week and adapting EPO when haemoglobin (Hb) fell below 10g/dL (adaptive strategy) or starting ribavirin at 1000mg per week while increasing EPO from the start of treatment (preventive strategy). RESULTS Patients treated with the adaptive strategy had lower median Hb levels (9.6 vs. 10.9g/dL, P=0.02) and more frequent median Hb levels below 10g/dL (58 vs. 5%, P=0.0007) despite lower median ribavirin doses (105 vs. 142mg/day, P<0.0001) than patients treated with the preventive strategy. There was a trend for more frequent transfusion in patients treated with the adaptive strategy than in patients treated with preventive strategy (50 vs. 20%, P=0.08). Compared to patients with normal renal function, ESRD patients had lower ribavirin concentrations during the first month (0.81 vs. 1.7mg/L, P=0.007) and similar concentrations thereafter. SVR was reached in 50%. CONCLUSIONS Pegylated interferon (Peg-IFN) and an adapted schedule of ribavirin are effective in ESRD patients. Increasing EPO from the start of treatment provides better haematological tolerance. The optimal dosage of ribavirin remains unresolved, in light of frequent side effects.
Collapse
|
76
|
Bendorf A, Kerridge I, Pussell B, Donadio C, Hesham A, Grassi G, Kanaki A, Barsotti M, Hertig A, Dubois-Xu YC, Buob D, Noel C, Rondeau E, Hazzan M, Dahle DO, Mjoen G, Marz W, Holme I, Fellstrom B, Jardine A, Holdaas H, Vincenti F, Larsen C, Alberu J, Duro Garcia V, Rostaing L, Rice K, Schnitzler M, Xing J, Agarwal M, Charpentier B. Transplantation / Clinical studies. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
77
|
Bharat S, Zhu M, Gay H, Michalski J, Santanam L, Noel C, Parikh P. SU-E-J-150: Applicability of a Point Fiducial-Based Model for the Prostatic Bed in Post-Prostatectomy Radiation Therapy Patients: An Expedited Dosimetric Analysis Using New Functionality in Philipsˈ Pinnacle3 Treatment Planning Systemˈs Research Version. Med Phys 2011. [DOI: 10.1118/1.3611918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
78
|
Li H, Thorstad W, Ramirez JG, Moore K, Li HH, Noel C, Low D, Mutic S. SU-E-T-295: Clinical Evaluations of a Novel Metal Artifact Reduction Technique for Helical CT Scans in Radiation Therapy. Med Phys 2011. [DOI: 10.1118/1.3612246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
79
|
Walker R, Ruderman I, Masterson R, Cohney S, Salvadori M, Conti P, Bertoni E, Durrbach A, Citterio F, Mulloy L, David-Neto E, Russ G, Vitko S, Zhang R, Xing J, Harler MB, Grinyo J, Rugiu C, Trubian A, Bernich P, Lupo A, Asbe-Vollkopf A, Pannu A, Hoefeld H, Gauer S, Gossmann J, Kachel HG, Froese S, Korom S, Geiger H, Hauser IA, Liefeldt L, Kluener C, Glander P, Giessing M, Gralla O, Neumayer HH, Budde K, Kroencke T, Liborio AB, Barros RM, Esmeraldo RM, Oliveira MLMB, Nogueira Paes FJV, Mendoza TR, Silva Junior GB, Daher EF, Siekierka-Harreis M, Bantis C, Kouri NM, Schwandt C, Rump LC, Ivens K, Slatinska J, Honsova E, Burgelova M, Slimackova E, Viklicky O, Tabernero G, Rivero K, Fernandez G, Canueto J, Garcia P, Fraile P, Lucas C, Tabernero JM, Bargnoux AS, Simon N, Garrigue V, Dupuy AM, Mourad G, Cristol JP, Yapici U, Kers J, Bemelman F, Roelofs J, Groothoff J, van der Loos C, van Donselaar-van der Pant K, Idu M, Claessen N, ten Berge I, Florquin S, Knap B, Dragonja Z, Dobnik S, Buturovic Ponikvar J, Ponikvar R, Kandus A, Bren A, Hauser IA, Kleemann J, Gauer S, Engel J, Winter S, Hoefeld H, Asbe-Vollkopf A, Brzoska M, Obermueller N, Geiger H, Schaeffeler E, Oldak M, Pazik J, Lewandowski Z, Sitarek E, Dabrowski M, Ploski R, Malejczyk J, Durlik M, Slubowska K, Urbanowicz A, Sadowska A, Lichodziejewska B, Kurnicka K, Galazka Z, Chmura A, Durlik M, Masin-Spasovska J, Spasovski G, Petrusevska G, Popov Z, Ivanovski N, Di Napoli A, Salvatori MF, Franco F, Di Lallo D, Guasticchi G, Sancho A, Gavela E, Beltran S, Kanter J, Alemany B, Crespo JF, Pallardo LM, Lionet A, Beuscart JB, Buob D, BenHenda A, Provot F, Hazzan M, Noel C, Galan-Sanchez F, Marin-Casanova P, Mazuecos A, Garcia-Alvarez T, Aznar E, Rodriguez-Iglesias M, Ossareh S, Salami M, Mohammad E, Hosseini M, Pawlik A, Chudek J, Kolonko A, Wilk J, Jalowiecki P, Wiecek A, Zyablitskaya E, Galkina E, Yushina E, Botelho C, Aires P, Santos L, Romaozinho C, Macario F, Alves R, Veiga P, Mota A, Yashi M, Yagisawa T, Kimura T, Nukui A, Fujiwara T, Sakuma Y, Ishikawa N, Iwabuchi T, Muraishi O, Glander P, Hambach P, Liefeldt L, Neumayer HH, Budde K, Esmen S, Keven K, Sengul S, Ozcan M, Ensari A, Tuzuner A, Calayoglu R, Nergizoglu G, Gullu Koca T, Koca N, Ersoy A, Faria B, Bustorff M, Barros F, Tavares I, Santos J, Ferreira I, Sampaio S, Pestana M, Keven K, Suvak B, Sengul S, Kurultak I, Calayoglu R, Tutkak H, Choi HM, Yang HN, Jo SK, Cho WY, Kim HK, Aybal Kutlugun A, Altun B, Akman U, Aki T, Turkmen E, Yildirim T, Altindal M, Yilmaz R, Yasavul U, Gullu Koca T, Koca N, Ersoy A, Thiem U, Heinze G, Gossler U, Perkmann T, Kainberger F, Muhlbacher F, Horl W, Borchhardt K, Sanchez-Escuredo A, Holgado S, Biosca C, Granada ML, Barluenga E, Lauzurica R, Romero R, Espinal A, Torregrossa V, Bayes B, Tomida K, Hamano T, Fujii N, Ichimaru N, Matsui I, Isaka Y, Rakugi H, Takahara S, Gavela E, Sancho A, Kanter J, Beltran S, Avila A, Crespo JF, Pallardo LM, Dor F, Massey E, Frunza M, Johnson R, Lennerling A, Loven C, Mamode N, Pascalev A, Sterckx S, Van Assche K, Zuidema W, Weimar W, Botelho C, Aires P, Santos L, Romaozinho C, Macario F, Alves R, Veiga P, Mota A, Allwin R, Gauer S, Roessel, Hoefeld H, Brzoska M, Buettner S, Gossmann J, Belwe V, Geiger H, Hauser IA, Apaza J, Gonzalez E, Polanco N, Bengoa I, Cadenillas C, Andres A, Morales JM, Rocha S, Fonseca I, Martins LS, Vidinha J, Dias L, Almeida M, Pedroso S, Henriques A, Cabrita A, Neretljak I, Mihovilovic K, Vidas Z, Jurenec F, Knotek M, Justa S, Minz R, Minz M, Anand S, Sharma A, Lacquaniti A, Donato V, Chirico V, Pettinato G, Buemi M, Galle J, Addison J, Perry P, Claes K, Farouk M, Guerin A, Kiss I, Winearls C, Di Giulio S, Basic-Jukic N, Slavicek J, Bubic-Filipi L, Kes P, Scholbach T, Wang HK, Yang AH, Loong CC, Wu TH, Abboud I, Antoine C, Serrato T, Lefaucheur C, Pillebout E, Gaudez F, Fieux F, Flamant M, Verine J, Viglietti D, Peraldi MN, Glotz D. Transplantation: clinical studies (2). Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.60] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
80
|
Ge J, Santanam L, Noel C, Parikh P. TU-G-BRC-05: Daily Respiratory Gating Window Adjustment Is Necessary for Abdominal Radiation Therapy Patients: A Retrospective Analysis with Simulation 4DCT and Daily Fluoroscopy. Med Phys 2011. [DOI: 10.1118/1.3613234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
81
|
Vantyghem MC, Balavoine AS, Caiazzo R, Kerr-Conte J, Noel C, Pattou F. Diabetes cell therapy: a decade later. MINERVA ENDOCRINOL 2011; 36:23-39. [PMID: 21460785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Type 1 diabetes is an intrinsically unstable condition because of the loss of both insulin secretion and glucose sensing. Guidelines to treat type 1 diabetes have become stricter since results from the Diabetes Control and Complications Trial (DCCT) demonstrated the close relationship between microangiopathy and HbA1c levels. Therapeutic strategies first require the treatment of underlying organic causes of the brittleness associated with the optimization of insulin therapy including continuous subcutaneous insulin infusion and glucose monitoring. Alternative approaches may still be needed for the most severely affected patients. During the last decade, islet transplantation has gone from an inconsistent 1-year rate of insulin independence of 10% to 80% and could reach 50% at 5 years, at the expense of non-negligible side effects. Among potential causes of islet transplantation success, sufficient islet mass and low levels of cellular autoimmunity are of critical importance. The main issues are currently the availability of an unlimited source of insulin-secreting cells, and the immunosuppressive drug side effects. Today, islet alone and islet after kidney transplantation are offered in a limited number of isolation centres, usually in clinical trials. Islet after kidney transplantation can be considered in type 1 diabetic patients with end-stage kidney disease that are ineligible for double kidney-pancreas transplantation. Islet transplantation alone is proposed to C-peptide negative adult diabetic patients with a body weight <80 kg or low daily insulin needs with creatinine clearance above 60 ml/min, albuminuria lower than 300mg/24H and without desire for pregnancy in women. Currently and until a more complete assessment of the 5- and probably 10-year overall benefit-risk ratio is available, islet transplantation remains a clinical research procedure.
Collapse
|
82
|
Mesbah R, Gobert P, Azar R, Gondran G, Noel C, Reberolle M, Bridoux F, Bataille P, Vanhille P. Néphrite interstitielle (NI) avec insuffisance rénale (IR) et syndrome de Gougerot-Sjögren (SGS) primaire : évolution à long terme chez 21 patients. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.03.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
83
|
Renard E, Palombi K, Gronfier C, Pepin JL, Noel C, Chiquet C, Romanet JP. Twenty-four Hour (Nyctohemeral) Rhythm of Intraocular Pressure and Ocular Perfusion Pressure in Normal-Tension Glaucoma. ACTA ACUST UNITED AC 2010; 51:882-9. [DOI: 10.1167/iovs.09-3668] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
84
|
Parikh P, Olsen J, Smith R, Noel C, Khan D, Tropper S, Mantz C. Do Interventions for Prostate Cancer Intrafraction Motion Make a Difference? Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
85
|
Olsen J, Noel C, Baker K, Santanam L, Michalski J, Parikh P. A Practical Method of Adaptive Radiotherapy for Prostate Cancer using Real-time Electromagnetic Tracking. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
86
|
Low D, Zhao T, Yang D, Lu W, Mutic S, Noel C, Hubenschmidt J, Parikh P, Bradley J. Free Breathing Motion Model: First Report of Patient Model Parameters. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
87
|
Marboeuf P, Delsart P, Hurt C, Villers A, Hossein-Foucher C, Beregi JP, Deklunder G, Noel C, Mounier-Vehier C. [Management of renal atrophy in hypertensive patients: experience in Lille]. Presse Med 2009; 39:e67-76. [PMID: 19854024 DOI: 10.1016/j.lpm.2009.07.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2008] [Revised: 06/24/2009] [Accepted: 07/08/2009] [Indexed: 10/20/2022] Open
Abstract
INTRODUCTION In the absence of specific treatment, patients with renal vascular disease develop renal atrophy. This population frequently has hypertension refractory to medical treatment. The patients who may respond to revascularization or at the worst to a nephrectomy must be identified to optimize their therapeutic management. METHODS We conducted an observational retrospective study of hypertensive patients with unilateral renal atrophy (renal height < 9 cm) followed at the Lille University Hospital Center from 1998 to 2006. Hypertension, renal clearance (by scintigraphy with MAG3), and hypersecretion of renin (segmental/selective venous renin samples) were studied. We subsequently classified the patients into 3 groups. Medical treatment was optimized for all. RESULTS The mean follow-up period was 1.3+/-0.2 years. Eight patients were treated medically (group 1). Endovascular revascularization was used to treat the subjects for which atrophic kidney function accounted for more than 10% of their total renal function and with stenosis of the renal artery (>70%) (group 2, n=19). Those with a small nonfunctional kidney (<10% of total renal function) and hypersecretion of renin (ratio>1.5 in relation to the contralateral kidney) underwent a nephrectomy (group 3, n=8). The reduction in systolic blood pressure (SBP) was 27 mm Hg and diastolic blood pressure (DBP) 14 mm Hg for the overall study population (p < 0.001), without any significant aggravation of renal function. In group 1, the reduction in blood pressure was lower, with medical treatment alone; SBP fell by 13 mm Hg and DBP by 4mm Hg (p=ns) ; this group had the lowest initial blood pressure. In group 2, revascularization made it possible to improve SBP by 26 mm Hg and DBP by 14 mm Hg (p < 0.01) without significant impairment of renal function. Group 3 showed the most spectacular improvement in blood pressure, with SBP dropping by 40 mm Hg and DBP by 19 mm Hg (p=0.016). But it was also in this group that we observed an aggravation in the rate of glomerular filtration with a nonsignificant reduction of 12.8 mL/min, nonetheless superior to that expected according to the preoperative scintigraphy. CONCLUSION The results of this work underline the importance of multidisciplinary management of patients with small ischemic kidneys. Preselection of patients in unstable clinical situations (refractory hypertension, progressive kidney failure, flash pulmonary edema) by isotopic and endocrinal renal evaluation provides a basis for deciding on treatment. The existence of a renin ratio >1.5 can identify the patients most likely to respond to nephrectomy. The reduction of renal function following nephrectomy must be considered in the discussion about treatment. The functional threshold initially defined at 10% may be lowered to 5%, to limit this postoperative reduction.
Collapse
|
88
|
Vantyghem MC, Balavoine AS, Kerr-Conte J, Pattou F, Noel C. Who should benefit from diabetes cell therapy? ANNALES D'ENDOCRINOLOGIE 2009; 70:443-8. [PMID: 19744642 DOI: 10.1016/j.ando.2009.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/08/2009] [Accepted: 08/08/2009] [Indexed: 10/20/2022]
Abstract
Type 1 diabetes are intrinsically unstable conditions because of the loss of both insulin secretion and glucose sensing. Guidelines to treat type 1 diabetes have become stricter since the Diabetes Control and Complications Trial (DCCT) results demonstrated the close relationship between microangiopathy and HbA1c levels, whereas the deleterious role of glucose variability on macroangiopathy has been more recently suspected. Therapeutic strategies first require the treatment of underlying organic causes of the brittleness whenever possible and, secondly, the optimization of insulin therapy using analogues, multiple injections and consideration of continuous subcutaneous insulin infusion. Alternative approaches may still be needed for the most severely affected patients, including islet transplantation. We propose islet after kidney transplantation in diabetic patients with end-stage kidney disease ineligible for double kidney-pancreas transplantation (i.e C peptide negative patients over 45 years of age or with severe macroangiopathy) if creatinine blood levels are stable below 20mg/l at least six months after kidney transplantation and steroid discontinuation. Islet transplantation alone is proposed to (1) C peptide negative diabetic patients, (2) aged 18-65 with a duration of diabetes of at least five years, (3) treated with intensive subcutaneous insulin therapy, but unable to obtain a glycated hemoglobin level below 7% without hypoglycemia and / or with brittleness and unpredictable hyper- and hypoglycemia altering quality of life, (4) with normal body weight (< 80 kg) and / or low daily insulin needs (the lower, the better), (5) with renal function close to normal (creatinine clearance above 60 ml/min with albuminuria lower than 300 mg/24 h), (6) with no desire for pregnancy in women. Currently and until more complete assessment of the 5-year overall benefit-risk ratio, islet transplantation remains a clinical research procedure. As already provided for other types of transplantation, and once recognized as a "routine" procedure, prioritization of enlisted patients for islet transplantation could be aided by the calculation of a score that should be determined by a multidisciplinary team.
Collapse
|
89
|
Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Sellier-Leclerc A, Dragon-Durey M, Noel C, Loirat C. Influence of genotype on clinical characteristics of atypical hemolytic uremic syndrome (aHUS) with pediatric and adult onset. Mol Immunol 2009. [DOI: 10.1016/j.molimm.2009.05.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
90
|
Vantyghem MC, Kerr-Conte J, Arnalsteen L, Sergent G, Defrance F, Gmyr V, Declerck N, Raverdy V, Vandewalle B, Pigny P, Noel C, Pattou F. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care 2009; 32:1473-8. [PMID: 19638525 PMCID: PMC2713623 DOI: 10.2337/dc08-1685] [Citation(s) in RCA: 105] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE To investigate the influence of primary graft function (PGF) on graft survival and metabolic control after islet transplantation with the Edmonton protocol. RESEARCH DESIGN AND METHODS A total of 14 consecutive patients with brittle type 1 diabetes were enrolled in this phase 2 study and received median 12,479 islet equivalents per kilogram of body weight (interquartile range 11,072-15,755) in two or three sequential infusions within 67 days (44-95). PGF was estimated 1 month after the last infusion by the beta-score, a previously validated index (range 0-8) based on insulin or oral treatment requirements, plasma C-peptide, blood glucose, and A1C. Primary outcome was graft survival, defined as insulin independence with A1C < or =6.5%. RESULTS All patients gained insulin independence within 12 days (6-23) after the last infusion. PGF was optimal (beta-score > or =7) in nine patients and suboptimal (beta-score < or =6) in five. At last follow-up, 3.3 years (2.8-4.0) after islet transplantation, eight patients (57%) remained insulin independent with A1C < or =6.5%, including seven patients with optimal PGF (78%) and one with suboptimal PGF (20%) (P = 0.01, log-rank test). Graft survival was not significantly influenced by HLA mismatches or by preexisting islet autoantibodies. A1C, mean glucose, glucose variability (assessed with continuous glucose monitoring system), and glucose tolerance (using an oral glucose tolerance test) were markedly improved when compared with baseline values and were significantly lower in patients with optimal PGF than in those with suboptimal PGF. CONCLUSIONS Optimal PGF was associated with prolonged graft survival and better metabolic control after islet transplantation. This early outcome may represent a valuable end point in future clinical trials.
Collapse
|
91
|
Parikh P, Wen J, Smith R, Noel C, Santanam L, Petersen J, Newell J, Dimmer S. SU-FF-J-50: Concurrent Wireless Electromagnetic Tracking and CT Imaging. Med Phys 2009. [DOI: 10.1118/1.3181342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
92
|
Palaniswaamy G, Noel C, Klein E. TH-D-BRD-08: Dose Perturbation Due To High Z Artifacts in IMRT Planning. Med Phys 2009. [DOI: 10.1118/1.3182662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
93
|
Roumenina L, Hue C, Liszewski MK, Miller E, Jablonski M, Blouin J, Dragon-Durey MA, Noel C, Loirat C, Sautes-Fridman C, Atkinson J, Frémeaux-Bacchi V. Super C3-convertases, formed by gain-of-function factor B or C3 mutant proteins are associated with atypical haemolytic uraemic syndrome with a poor outcome. Mol Immunol 2008. [DOI: 10.1016/j.molimm.2008.08.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
94
|
Noel C, Klein E, Moore K. SU-GG-J-18: A Surface-Based Respiratory Surrogate for 4D Imaging. Med Phys 2008. [DOI: 10.1118/1.2961575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
95
|
Yera H, Zamfir O, Bourcier T, Viscogliosi E, Noel C, Dupouy-Camet J, Chaumeil C. The genotypic characterisation of Acanthamoeba isolates from human ocular samples. Br J Ophthalmol 2008; 92:1139-41. [DOI: 10.1136/bjo.2007.132266] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
96
|
Abramowicz D, Hadaya K, Hazzan M, Broeders N, Hoang AD, Ghisdal L, Noel C, Wissing KM. Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects. Nephrol Dial Transplant 2008; 23:3727-9. [PMID: 18567692 PMCID: PMC2568008 DOI: 10.1093/ndt/gfn332] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
We retrospectively reviewed our experience with 45 kidney transplant recipients (KTR) that were switched from CNI to SRL, mainly for chronic allograft dysfunction (CAD) (41/45). The mean serum creatinine at switch was 2.5 ± 0.8 mg/dl. At 1 year, patient survival was 93%. Death-censored graft survival was 67% at 1 year and 54% at 2 years. SRL was stopped because of severe side effects in 15 patients. Among these, eight patients developed ‘de novo’ high-grade proteinuria. Univariate analysis revealed that (1) a higher SRL level at 1 month was a predictor of SRL withdrawal due to severe side effects (P = 0.006), and (2) predictors of graft failure after SRL conversion were low SRL loading dose (P = 0.03) and a higher creatinine level at conversion (P = 0.003). In conclusion, the therapeutic index of SRL in patients suffering from CAD is narrow, with high exposure triggering serious adverse events that may mandate SRL discontinuation, while too low exposure may expose patients to under-immunosuppression and graft loss.
Collapse
|
97
|
Santanam L, Esthappan J, Noel C, Mutic S, Goddu S, Parikh P, Low D. SU-GG-J-38: Assessment of Conebeam CT Image Quality in the Presence of An Electromagnetic Tracking System. Med Phys 2008. [DOI: 10.1118/1.2961596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
98
|
Goddu S, Noel C, Chaudhari S, Parikh P, Khullar D, Santanam L, Low D. TH-C-350-09: 4D Treatment Planning and Dosimetric Validation of Helical Tomotherapy Treatments of Moving Tumors. Med Phys 2008. [DOI: 10.1118/1.2962834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
99
|
Zhao T, Bradley J, Noel C, Yalavarthy P, Parikh P, Yang T, Yang D, Mutic S, Low D. MO-E-AUD C-06: Application of 5D Breathing Motion Model for Monitoring Radiation Damage. Med Phys 2008. [DOI: 10.1118/1.2962395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
100
|
ElNaqa I, Apte A, Yang D, Noel C, Bradle J, Deasy J. WE-E-AUD C-07: A Robust Approach for Estimating Tumor Volume Change During Radiotherapy of Lung Cancer. Med Phys 2008. [DOI: 10.1118/1.2962788] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|